The AML1-ETO fusion protein resulting from this translocation recruits cellular factors that enhance hematopoietic stem cell self-renewal, inhibit hematopoietic differentiation and promote cell proliferation, phenomena directly associated with the development of AML [5]. Here, RUNX1T1 is linked to acute myeloid leukemia.